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The actions of polymyxin B, rabbit polymorphonuclear lysosome extracts, 14 polycationic peptides (including
defensin NP-2, cecropin P1, lactoferricin B, and active peptides from cationic protein 18 and bactenecin),
EDTA, and Tris on Brucella spp. were studied, with other gram-negative bacteria as controls. Brucella spp. were
comparatively resistant to all of the agents listed above and bound less polymyxin B, and their outer mem-
branes (OMs) were neither morphologically altered nor permeabilized to lysozyme by polymyxin B concen-
trations, although both effects were observed for controls. EDTA and peptides increased or accelerated the
partition of the hydrophobic probe N-phenyl-naphthylamine into Escherichia coli and Haemophilus influenzae
OMs but had no effect on Brucella OMs. Since Brucella and H. influenzae OMs are permeable to hydrophobic
compounds (G. Martı´nez de Tejada and I. Moriyo´n, J. Bacteriol. 175:5273–5275, 1993), the results show that
such unusual permeability is not necessarily related to resistance to polycations. Although rough (R) B. abortus
and B. ovis were more resistant than the controls were, there were qualitative and quantitative differences with
smooth (S) brucellae; this may explain known host range and virulence differences. Brucella S-lipopolysaccha-
rides (LPSs) had reduced affinities for polycations, and insertion of Brucella and Salmonella montevideo S-LPSs
into the OM of a Brucella R-LPS mutant increased and decreased, respectively, its resistance to cationic
peptides. The results show that the core lipid A of Brucella LPS plays a major role in polycation resistance and
that O-chain density also contributes significantly. It is proposed that the features described above contribute
to Brucella resistance to the oxygen-independent systems of phagocytes.
Brucella spp. are gram-negative pathogens that infect both
animals and humans (5). This genus includes species whose
outer membranes (OMs) contain smooth lipopolysaccharides
(S-LPSs) (B. abortus, B. melitensis, B. suis, and B. neotomae) as
well as others (B. ovis and B. canis) that lack true O chains and
are designated naturally rough (R) brucellae because of their
similarities with R mutants of the S Brucella species (5). The
survival of Brucella spp. within mononuclear cells has been well
documented (3, 5, 32–34), and it has been shown that B. abor-
tus cells elicit little respiratory burst and only reduced (34) but
significant (25) levels of degranulation in polymorphonuclear
(PMN) leukocytes. Moreover, Riley and Robertson (33, 34)
found that compared with R-LPS Salmonella typhimurium mu-
tants, both S-LPS and R-LPS B. abortus cells are resistant to
the oxygen-independent mechanisms of PMN cells. More re-
cently, Rasool et al. (32) found that highly purified prepara-
tions of B. abortus S-LPS are at least 200 times less active in
stimulating PMN cells than S. typhimurium S-LPS preparations
are, an observation that explains the reduced respiratory burst
and degranulation induced by B. abortus (33).
The resistance of Brucella spp. to oxygen-independent mech-
anisms has not been explained on a structural basis. Oxygen-
independent mechanisms include the synergistic actions of sev-
eral cationic proteins and peptides which, in a first step, bind to
OM anionic targets and render the cell envelope permeable
and susceptible to lytic enzymes, thereby blocking cell func-
tions that depend on membrane integrity (11, 18, 40, 45).
Accordingly, the virulence of some intracellular gram-negative
bacteria, such as Salmonella spp., is linked in part to resistance
to cationic peptides (11, 41), including not only peptides from
phagocytes but also bactericidal cationic peptides from other
animal and bacterial sources that act first on the OM by a
closely related mechanism (11, 45). In this work, we probed the
OMs of S and R Brucella spp. with various cationic peptides
and found reduced affinities for all of them, thereby providing
experimental evidence for the hypothesis (20, 32) that in Bru-
cella spp., resistance to oxygen-independent systems is linked
to the OM and S-LPS properties. In addition, since ionic
groups are the target of polycations and part of the OM barrier
to hydrophobic agents, we also studied whether the unusual
permeability of Brucella OMs to such agents (21) was neces-
sarily related to resistance to polycations. Appropriate controls
of other gram-negative bacteria were used throughout these
studies.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used are listed
in Table 1. B. abortus, B. melitensis, Yersinia enterocolitica, Escherichia coli, and
Salmonella montevideo were grown in tryptic soy broth (Oxoid Ltd., London,
England), and B. ovis and Haemophilus influenzae were grown in the same
medium with 0.5% yeast extract or 3% nutrient supplement (Fildes; Difco
Laboratories, Detroit, Mich.), respectively. Bacteria were harvested (5,000 3 g,
15 min, 48C) in the exponential phase of growth and for sensitivity, polymyxin B
binding, and OM stability studies (see below) were resuspended immediately in
the appropriate buffer. Alternatively, when sensitivity was tested according to
protocol B (see below), bacteria were grown on blood (Brucella spp.) or Mac-
Conkey (E. coli) agar plates. For S-LPS extraction, bacteria were propagated in
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2-liter flasks (500 ml per flask) on an orbital shaker (200 rpm) and, when
appropriate, inactivated with 0.5% phenol at 378C for 24 h.
LPS preparations. The S-LPSs of B. abortus 2308, S19, E. coli serotype O111,
and S. montevideo were used as representatives of Brucella- and enterobacterial-
type S-LPSs. B. abortus S-LPS (fraction 5) was obtained from the phenol phase
of a water-phenol extract and purified by treatment with chaotropic agents and
detergents according to published procedures (22, 23). Alternatively, fraction 5
was dispersed (20 mg/ml) by sonication in 5 mM MgCl2–10 mM Tris-HCl (pH
7.5) and digested with nucleases (20 mg each of DNase I and RNase A [Sigma
Chemical Co., St. Louis, Mo.] per ml for 4 h at 378C) and proteinase K (65 mg/ml
[E. Merck, Darmstadt, Germany] for 24 h at room temperature), and S-LPS was
recovered by ultracentrifugation (100,000 3 g, 6 h, 48C) and freeze dried. By
standard analytical methods (6), these S-LPS preparations had 0.8% 2-keto-3-
deoxyoctonic acid (KDO), 2.9% protein, and up to 6% free lipids distributed
among ornithine lipids and the major classes of Brucella phospholipids (43). In
some experiments, free lipids were removed by threefold extraction with water-
chloroform-methanol (1:1:2). E. coli O111 and S. montevideo S-LPSs were ob-
tained by the standard phenol-water method (6) and purified with nucleases and
proteinase K as described above. These preparations had 1.5% KDO, less than
1.0% protein, and trace amounts of free lipids. By sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining for LPS
(44), all of these preparations showed the characteristic pattern of S-LPSs.
Cationic peptides. The characteristics and reported actions of the peptides
used are summarized in Table 2. Polymyxin B (sulfate), egg lysozyme, poly-L-
lysine, poly-L-ornithine, cecropins, melittin, magainins, and lactoferrin were pur-
chased from Sigma. Lactoferricin B was kindly provided by W. Bellamy (Mori-
naga Dairy Company, Higashihara, Japan), the cationic protein 18 (CAP18)
peptide (amino acids 106 through 125) and bactenecin peptides 5 (amino acids
0 through 31) and 7 (amino acids 1 through 35) were provided by R. Gennaro
and D. Romeo (Department of Biochemistry, Biophysics, and Chemistry of
Macromolecules, Trieste University, Trieste, Italy), and defensin NP-2 was pro-
vided by R. I. Lehrer (Department of Medicine, University of California, Los
Angeles).
Lysosomal extract from rabbit PMN leukocytes. White New Zealand rabbits
weighing 2.5 kg each were sensitized by three intraperitoneal injections of 150 ml
of 0.1% oyster glycogen in sterile saline at 378C administered at weekly intervals.
Four hours after the last injection, each rabbit was anesthetized, the peritoneal
cavity was cannulated, and the exudate was collected in saline with 50 mg of
heparin per liter. Over 90% of cells were PMN leukocytes, as judged by Giemsa
staining of smears. After assessment of cell viability (trypan blue exclusion test),
PMN leukocytes were suspended (107 to 108 cells per ml) in 0.34% sucrose and
disrupted in a Potter-type homogenizer. The homogenate was clarified (125 3 g,
15 min, 48C), cytoplasmic granules were sedimented (20,000 3 g, 30 min, 48C),
and cationic components were extracted with HCl as described previously (14).
Sensitivity assays. Depending on the amount of peptide available, bacterial
sensitivity was measured as the effect of increasing concentrations of an agent on
cell viability (protocol A) and/or as the percentage of cell viability after exposure
to a single concentration of each agent (protocol B).
(i) Protocol A. The assay described by Riley and Robertson (34) was used with
some modifications. Stock solutions of agents were prepared in sterile 0.133 M
NaCl–0.1 M NaH2PO4 (pH 4.6) or 10 mM phosphate buffer (pH 7.0), and serial
dilutions were made directly in sterile 96-well tissue culture clusters (Costar,
Cambridge, Mass.) by using the same buffer as a diluent (100 ml per well).
Bacteria were resuspended in the same buffer solution at approximately 4 3 104
CFU/ml, 100 ml of this suspension was dispensed in duplicated series of wells (4
3 103 CFU per well in 200 ml), and plates were incubated for 1 h at 378C. Viable
counts were performed by spreading 100 ml from each well on tryptic soy agar
(Oxoid Ltd.) plates, and the results were expressed as the percentage of survival
with respect to that of controls incubated without the appropriate agent (no
bacterial multiplication occurred under those conditions).
TABLE 1. Bacterial strains used in this study
Strain Characteristics Reference
B. melitensis 16M S-LPS, virulent, biotype 1, serotype M 1
B. melitensis Ether S-LPS, virulent, biotype 3, serotype AM 1
B. melitensis 115 R-LPS, avirulent 1
B. abortus 2308 S-LPS, virulent, biotype 1, serotype A 19
B. abortus S19 S-LPS, vaccine strain, biotype 1, serotype A 1
B. abortus B3196 S-LPS, virulent, biotype 5, serotype M 1
B. abortus 45/20 R-LPS, attenuated 33
B. abortus RB51 R-LPS, attenuated, derived from B. abortus 2308 37
B. ovis Reo 198 Natural R-LPS species, CO2-independent strain 1
E. coli O111 K58H2 S-LPS, enteropathogenic, used in OM permeability studies 21
E. coli ATCC 29648 S-LPS, used in studies of sensitivity to defensins 38
E. coli K-12 ATCC W1485 R-LPS of Ra chemotype
S. montevideo SH94 S-LPS, serogroup D1 16
H. influenzae 9193 Serovar b, clinical isolate 21
Y. enterocolitica MY79 Serotype 9, LPS O chain of Brucella serotype A 26
TABLE 2. Origins and relevant characteristics of cationic peptides
Peptide(s) Origin(s) Relevant features Reference(s)
Bactenecin Bovine neutrophils Amphiphilic; bactericidal for gram-negative bacteria; permeabilizes OMs
and cytoplasmic membranes
10
CAP18 Rabbit PMN cells Bactericidal; binds to LPS; increases cell permeability 13
Cecropin P1 Pig intestine Bactericidal; forms channels in lipid bilayers 17, 39
Cecropin A Cecropia moth hemolymph Amphiphilic (two alpha-helices); bactericidal; forms voltage-dependent
channels in lipid bilayers
2
Defensin NP-2 PMN cells Binds to LPS; forms voltage-dependent channels in lipid bilayers 15, 38
Lactoferrin Milk and mucosal secretions Complex structure (alpha-helix and beta-sheet); Fe and divalent cation che-
lator; bactericidal; binds to OMs
9, 28, 48
Lactoferricin B OM-binding peptide derived from lactoferrin 48
Lysozyme Egg white Muramidase; binds to LPS 42
Magainins 1 and 2 Frog skin and stomach Amphiphilic alpha-helix; bactericidal; binds to LPS; forms channels in
membranes
31, 45
Melittin Bee venom Amphiphilic (two alpha-helices); bactericidal; binds to LPS; forms voltage-
dependent channels in membranes
7, 12, 45
Poly-L-lysine Synthetic Alpha-helix; bactericidal for gram-negative bacteria; binds to LPS 45
Poly-L-ornithine Synthetic Bactericidal for gram-negative bacteria 45
Polymyxin B Bacteria Amphiphilic lipopeptide; bactericidal; binds to LPS; produces OM blebbing 45
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(ii) Protocol B. Bacteria were suspended in 10 mM phosphate buffer (pH 7.0)
at approximately 4 3 106 CFU/ml, and 100-ml aliquots were mixed with 10 to 20
mg of the appropriate agent (suspended in 3 ml of deionized distilled water), and
the mixture was incubated at 378C for 20 or 180 min, depending on the agent (see
footnotes to Table 3). For CFU counting, the suspension was diluted with 900 ml
of buffer and 100 ml was plated out. All experiments were run in quadruplicate,
and the results were expressed as the percentage of inhibition (mean 6 standard
deviation) of controls without the agent.
Binding of polymyxin by viable cells. Cell suspensions (4.5 3 1010 CFU/ml for
Brucella spp. and 1010 CFU/ml for E. coli and Y. enterocolitica serotype O:9) were
prepared in 0.133 M NaCl–0.1 M NaH2PO4 (pH 4.6), and serial dilutions were
made in 2-ml Eppendorf-type tubes by using the same buffer solution. An equal
amount of polymyxin B was added to each tube (350 U/ml of cell suspension),
and after incubation for 30 min at 378C, cells were removed by centrifugation
(12,000 3 g, 15 min). To measure unbound polymyxin B, 3-mm-diameter wells
were punched on petri dishes with peptone-glucose-agar containing 107 CFU of
E. coli K-12 per ml, 50-ml aliquots of supernatants were dispensed into wells, and
plates were incubated overnight. The amount of polymyxin B was estimated from
the diameter of the inhibition halo by comparison with polymyxin B standards on
the same plate.
Assessment of OM damage. (i) Electron microscopy. Bacteria were resus-
pended in 10 mM phosphate-buffered saline (PBS; pH 7.2) and incubated with
polymyxin B (500 U/ml) for 20 min at 378C. Cells were sedimented (12,000 3 g,
5 min), fixed first in 4% glutaraldehyde–0.1 M cacodylate buffer (pH 7.2) for 1 h
at 48C, washed with 2 M sucrose—50 mM cacodylate (pH 7.2), and fixed again
in 1% OsO4–100 mM cacodylate (pH 7.2) for 2 h at 48C. The fixing solution was
removed with two washes of 340 mM Veronal sodium (pH 7.4), and bacteria
were stained with 0.5% uranyl acetate in the same buffer (30 min, 48C). After two
additional Veronal washes, bacteria were resuspended in molten Noble agar
(Difco Labortories), the gel was included in Epon-812, and thin sections were
contrasted with uranyl acetate. Observations were carried out with a Zeiss
EM10CR electron microscope (Carl Zeiss Germany, Oberkochen, Germany).
(ii) Permeability to lysozyme. Exponentially growing cells were resuspended in
10 mM N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid (HEPES; pH 7.2)
at an optical density (at 500 nm) of 0.8, and lysozyme (50 mg/ml) and polymyxin
B (100 U/ml) were added. Incubation was performed at room temperature, and
cell lysis was monitored by measuring the A500. Since sensitivity to lysozyme has
been shown for Brucella spp. (8) and E. coli, cell lysis was taken as evidence of
lysozyme uptake (46). Controls were bacterial suspensions with only lysozyme or
polymyxin B or without either agent.
(iii) Fluorimetry. Exponentially growing cells were resuspended in 1 mM
KCN–10 mM PBS (pH 7.2) (Brucella spp. and H. influenzae) or 1 mM KCN–10
mM HEPES (pH 7.2) (E. coli) at an optical density (at 600 nm) of 0.48 and
transferred immediately to 1-cm-diameter fluorimetric cuvettes. After 15 to 20 s,
N-phenyl-naphthylamine (NPN; 500 mM in acetone) was added to a final con-
centration of 10 mM. Peptides and EDTA were added either before or after NPN
at the following final concentrations to cuvettes: EDTA, 5 mM; polymyxin B, 100
U/ml; melittin, 10 mg/ml; cecropin P1, 6.5 mg/ml; magainins 1 and 2, 30 mg/ml
(each); and lysosomal extract, 20 mg of protein per ml. In preliminary experi-
ments, the concentrations of peptides listed above were selected because they
were bactericidal (see Results) and did not generate quenching. Fluorescence
was monitored at 208C with an LS-50 fluorimeter (Perkin-Elmer Ltd., Bea-
consfield, England) set as follows: excitation, 350 nm; emission, 420 nm; slit
width, 2.5 nm. The results were expressed in relative fluorescence units (RFU).
Binding of polymyxin B and cationic peptides by S-LPSs. Appropriate
amounts of S-LPS were dispersed by ultrasonic treatment (10 W, 20 s) in
deionized distilled water or 0.133 M NaCl–0.1 M NaH2PO4 (pH 4.6), and the
solutions were clarified by brief centrifugation (12,000 3 g, 15 s). By using those
suspensions, 5 mg of the agent to be tested was mixed with 1.25 to 25.0 mg of
S-LPS in a volume of 50 ml, aliquots of this mixture were dispensed into wells
punched in peptone-glucose-agar plates previously inoculated with E. coli as
described above, and plates were incubated overnight. For each agent, the effect
of S-LPS was estimated as the percentage of reduction in the halo of inhibition
with respect to that obtained with the corresponding agent and no LPS.
The amount of polymyxin B bound by S-LPS was measured by high-perfor-
mance liquid chromatography (HPLC). Aliquots of S-LPS suspensions were
incubated (10 min, 378C) with increasing amounts of polymyxin B, and the
unbound lipopeptide was separated on a TSK3000SW column (30.0 by 0.8 cm)
(TosoHaas GmbH, Stuttgart, Germany) fitted to a 625 LC unit (Waters Asso-
ciates, Inc., Milford, Mass.) with a Waters 486 detector set at 220 nm (previously
calibrated by using polymyxin B as the standard). HPLC was performed at 0.5
ml/min in 13 mM NaCl–10 mM NaH2PO4 (pH 4.6).
Coating of R B. abortus with S-LPSs. One hundred microliters of a B. abortus
45/20 suspension (8 3 107 CFU/ml in 10 mM phosphate buffer [pH 7.0]) was
mixed with 100 ml of a suspension (20 mg/ml) of S-LPS from either B. abortus S19
or S. montevideo, and the mixture was sonicated briefly (three pulses of 1 s).
After incubation for 18 h at 408C, cells were washed three times and resuspended
in 200 ml of 10 mM phosphate buffer (pH 7.0), and 100 ml of this suspension was
incubated for 20 min with 10 mg of the agent to be tested and then plated out for
CFU counting. Experiments were run in quadruplicate, and the results were
expressed as the percentage of inhibition (mean 6 standard deviation) of con-
trols without the agent. Insertion of S-LPS into the OM of B. abortus 45/20 was
shown by immunofluorescence (16) with either rat monoclonal antibody to the S.
montevideo O chain (D1 serogroup) (kindly provided by A. Weintraub, Depart-
ment of Clinical Bacteriology, Karolinska Institute, Huddinge Hospital, Hud-
dinge, Sweden) or mouse monoclonal antibody to the B. abortus O-chain com-
mon C/Y epitope (35) and rabbit anti-rat immunoglobulin G or anti-mouse
immunoglobulin-fluorescein isothiocyanate conjugates (Sigma). Compared with
that of uncoated controls, coating had no effect on the viability of B. abortus
45/20.
RESULTS
Effects of EDTA, polymyxin B, and cationic peptides on cell
viability. The effects of increasing concentrations of polymyxin
B on the viabilities of B. abortus 2308, S and R E. coli, and Y.
enterocolitica O:9 are illustrated in Fig. 1. In this assay, B.
abortus 2308 was remarkably more resistant than the controls
were, and identical results were obtained with the remaining S
and R Brucella strains within the range of concentrations
tested (data not shown). It can also be seen that the E. coli R
strain was more sensitive than the S strain was and that B.
abortus O-chain-bearing Y. enterocolitica O:9 was less affected
by polymyxin B than E. coli was at concentrations of less than
50 U/ml. Similar experiments were performed with melittin,
cecropin P1, magainins, and lysosomal extract (Fig. 1), and the
results resembled those obtained with polymyxin B in that B.
abortus was resistant to peptide and lysosomal extract concen-
trations that were lethal for E. coli.
Table 3 shows the effects of a single concentration of each
cationic peptide, Tris, and EDTA on the viabilities of S B.
abortus, an R B. abortusmutant, and B. ovis. It can be seen that
the three Brucella strains were more resistant to all of the
agents tested than the E. coli control was, with the conspicuous
exception of bactenecin 7 and B. ovis. This peptide reduced the
growth of E. coli by 97%, and although it had a limited effect
on S and R B. abortus, it showed maximal activity on B. ovis
(100% growth reduction). The peptides that were more active
on S B. abortus (strain S19) were polymyxin B and lactoferricin
B, and although the results of both protocols were in good
agreement (Fig. 1 and Table 3), protocol B also showed that
the S B. abortus strain was more resistant than the homologous
R strain was (Table 3). B. ovis showed a sensitivity spectrum
somewhat different from that of B. abortus, since in addition to
bactenecin 7, it was comparatively sensitive to poly-L-ornithine
and poly-L-lysine. No pattern of activity that related to the
FIG. 1. Effects of polymyxin B (upper left panel), melittin and cecropin P1
(upper right panel), magainins 1 and 2 (lower left panel), and lysosomal extract
(lower right panel) on the viabilities of B. abortus 2308 (E), Y. enterocolitica O:9
(), E. coli K-12 (n), and E. coli O111 K58H2 (h).
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known structural features (Table 2) of these peptides was ob-
served.
Binding of polymyxin B by live cells. The results of poly-
myxin B binding experiments are presented in Fig. 2. Whereas
1010 CFU of E. coli and Y. enterocolitica O:9 bound over 300 U
of polymyxin B, the same number of Brucella CFU bound less
than 50 U of polymyxin B. No differences between S B. abortus
and B. melitensis and their respective R mutants were observed
within the range of polymyxin B concentrations tested (Fig. 2).
In these experiments, HPLC and SDS-PAGE analyses of the
supernatants of cells treated with polymyxin B showed the
release of large amounts of medium- to low-molecular-weight
materials by E. coli, not B. abortus (data not shown).
Assessment of OM damage by EDTA, polymyxin B, and
cationic peptides. Figures 3A and B are electron microscope
pictures of E. coli O111 and B. abortus 2308 cells exposed to
polymyxin B. Whereas this treatment induced extensive OM
blebbing in the control, it had no effect on B. abortus 2308.
Figure 3C shows that polymyxin B increased the permeability
of E. coli O111 to lysozyme, as demonstrated by the turbidity
drop (cell lysis) of the cell suspension. In contrast, the turbidity
of the B. abortus 2308 suspension remained constant (Fig. 3C).
E. coli K-12 and B. abortus RB51 also gave equivalent results;
viability was 100% for B. abortus and less than 5% for E. coli
at the end of this experiment.
The possibility of more subtle changes in cell surfaces was
studied by examining the partition of NPN into OMs (Fig. 4),
with bacteria with OM permeability properties different from
(E. coli) and similar to (H. influenzae) those of Brucella spp.
used as controls. In the absence of EDTA, polymyxin B, and
cationic peptides, only a limited amount of NPN was parti-
tioned into the OM of E. coli O111, as shown by the small (20
RFU) increase in fluorescence measured after NPN addition
(Fig. 4, upper left panel, discontinuous line). In H. influenzae
(Fig. 4, middle panel, discontinuous line), a progressive in-
crease in fluorescence was observed after NPN addition, a
result which is due to the accessibility of the hydrophobic
pathway in this OM (21). Although the OMs of controls had
almost opposite barrier properties, both were stabilized by
divalent cations since EDTA caused a small but significant
increase in fluorescence in E. coli (up to 45 RFU) (Fig. 4,
upper left panel, continuous line) and an acceleration in the
kinetics of NPN entry inH. influenzae (Fig. 4, middle left panel,
continuous line). In agreement with these results, the peptides
tested (polymyxin B, melittin, cecropin P1, and magainins 1
and 2) brought about a sharp increase (up to 120 RFU) in the
entry of NPN into the OM of E. coli O111 (Fig. 4, upper right
panel) and accelerated NPN uptake in H. influenzae (Fig. 4,
middle right panel). In contrast, although NPN partitioned
spontaneously into B. abortus OMs (Fig. 4, lower left panel,
discontinuous line), the kinetics of NPN uptake into B. abortus
2308 OMs was not altered by either EDTA or the peptides
tested (Fig. 4, lower panels, continuous lines). Additional con-
trols performed with heat-shocked B. abortus 2308 showed a
quick increase in fluorescence (Fig. 4, lower right panel, dis-
continuous line), confirming that OM damage accelerates the
partition of NPN into the OM. Similar results were obtained
with the remaining B. abortus and B. melitensis strains (data not
shown). Finally, NPN uptake by E. coli O111 was promoted by
lysosomal extract, particularly in combination with EDTA, but
lysosomal extract had no effect on B. abortus 2308 under the
same conditions (data not shown).
Binding of polymyxin B and cationic peptides by S-LPSs. As
a first approach, the binding of peptides by S-LPSs was as-
sessed as the reduction in peptide antibiotic activity after in-
cubation with the S-LPS tested. At the maximal amount tested
(25 mg), S. montevideo S-LPS caused 70 to 80% reductions in
the activities of magainins, melittin, CAP18 peptide, cecropins,
and polymyxin B and a 47% reduction in the activity of lacto-
ferricin B. With B. abortus S-LPS, there were reductions of
66% for polymyxin B; of about 50% for cecropin P1, magain-
ins, and melittin; and of only 15% for CAP18 peptide, cecropin
A, and lactoferricin B.
Since polymyxin B was the agent with the highest affinity for
B. abortus S-LPS, direct measurements of the amounts of poly-
FIG. 2. Polymyxin B binding by increasing amounts of viable cells of B.
abortus 2308 (E), B. abortus RB51 (F), B. melitensis 115 (:), Y. enterocoliticaO:9
(), E. coli K-12 (n), and E. coli O111 (h).
TABLE 3. Activities of cationic peptides, EDTA, and Tris
against E. coli and S and R brucellaea
Agent
Activity against:
E. coli B. abortusS19
B. abortus
45/20
B. ovis
Reo 198
Bactenecin 7 97.3 6 0.7 1.4 6 0.8 8.6 6 2.2 100 6 0.0
Bactenecin 5 76.8 6 5.2 0.6 6 0.7 5.9 6 1.1 11.9 6 1.4
CAP18 91.1 6 3.0 1.1 6 0.8 9.9 6 1.7 14.3 6 2.5
Cecropin Ab 100 0.4 0.5 0.6
Cecropin P1b 97.8 4.9 22.5 24.0
Defensin NP-2c 93.9 6 3.7 0.6 6 0.4 1.5 6 0.3 NDd
Lactoferricin Be 93.9 6 1.2 10.9 6 1.5 23.1 6 1.0 25.6 6 0.5
Lactoferrinf 85.8 6 1.9 0.6 6 0.3 9.5 6 0.7 15.6 6 2.3
Lysozymeg 81.1 6 2.5 7.0 6 2.2 27.6 6 1.5 30.3 6 1.8
Magainin 1b 84.9 0.0 0.5 0.9
Magainin 2b,e 93.7 1.0 1.3 2.4
Melittin 100.0 6 0.0 0.6 6 0.3 23.9 6 1.0 32.8 6 1.5
Poly-L-lysine 99.6 6 0.3 0.5 6 0.3 0.95 6 1.3 55.9 6 2.3
Polymyxin B 100.0 6 0.0 19.0 6 2.1 31.6 6 2.5 39.9 6 2.6
Poly-L-ornithine 99.5 6 0.4 0.9 6 0.7 14.7 6 3.4 57.2 6 4.1
EDTAg 97.3 6 0.8 0.9 6 0.7 2.6 6 1.4 6.7 6 4.6
Trisg 76.6 6 2.0 1.4 6 1.1 2.2 6 2.1 3.4 6 1.5
a Unless indicated otherwise, activity is expressed as the percentage of inhibi-
tion (mean 6 standard deviation) after exposure for 20 min to 10 mg of the
indicated agent per ml.
b Only one assay was performed.
c Incubation was carried out for 90 min.
d ND, not done.
e Incubation was carried out for 180 min.
f Incubation was carried out for 180 min with 10 mg of the agent per ml and 10
mg of lysozyme per ml.
g Incubation was carried out for 180 min with 200 mg of the agent per ml.
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myxin B bound by the S-LPSs of B. abortus 2308 and E. coli
O111 were carried out by HPLC analysis of S-LPS–polymyxin
B mixtures. The results showed that on the basis of either dry
weight (Fig. 5A) or polymyxin B bound by nanomoles of KDO
(Fig. 5B), the S-LPS of B. abortus 2308 bound less polymyxin B
than did the S-LPS of E. coli O111. The results did not change
substantially when the S-LPSs of B. abortus S19 and S. mon-
tevideo were used or when B. abortus S-LPSs were purified by
different protocols. No differences were observed between B.
abortus S-LPS preparations which contained phospholipids
and ornithine lipids and those from which free lipids had been
removed by solvent extraction (data not shown).
Effects of polymyxin B and cationic peptides on R B. abortus
coated with S-LPSs. Compared with the sensitivities of S B.
abortus and E. coli, R B. abortus 45/20 had an intermediate
sensitivity to polycationic molecules (Table 3). By taking ad-
vantage of this observation, an experimental protocol was de-
signed to test the activities (percentages of growth inhibition)
of polycations on R B. abortus 45/20 cells coated with S-LPSs
from resistant (S B. abortus) and sensitive (enterobacteria)
bacteria (Table 4). Coating with B. abortus S-LPS brought
about significant increases in resistance to the CAP18 peptide,
lactoferricin B, melittin, polymyxin B, and poly-L-ornithine
which paralleled the higher resistance observed for the S B.
abortus strain in the same sensitivity assay (Table 3). In con-
trast, coating with S. montevideo S-LPS rendered B. abortus
45/20 sensitive to the agents tested (Table 4) at levels close to
those observed for S-LPS enterobacteria (Table 3).
DISCUSSION
Previous studies have shown that the Brucella cell envelope
has permeability properties (21) and sensitivities to detergents
and EDTA (21, 24) that are different from those common to
gram-negative bacteria, and on this basis, a relationship be-
tween Brucella OM properties and pathogenicity has been sug-
gested (20, 32). In this work, B. abortus, B. melitensis, and B.
ovis were studied for their resistance to Tris, polymyxin B,
lysosomal extract, and bactericidal cationic peptides, including
several (bactenecins 5 and 7, CAP18 peptide, cecropin P1,
defensin NP-2, lactoferrin, and lysozyme) that are physiologi-
cal in mammals. In two complementary protocols, those agents
manifested their lethal actions on controls (E. coli and Y.
enterocoliticaO:9), but with one exception (bactenecin 7 and B.
ovis), they showed only limited actions on Brucella spp. The
fact that Brucella spp. were equally resistant to peptides with
various structures and some differences in reported actions
(Table 2) suggests that resistance occurs at an early step com-
mon to all of these peptides, and insensitivity to EDTA hinted
at the lack of OM ionic groups for electrostatic binding. This
hypothesis was tested first with polymyxin B. The results
showed that both R and S Brucella cells bound comparatively
reduced amounts of polymyxin B and that this potent lipopep-
tide did not cause OM morphological alterations or perme-
ability to lysozyme under conditions in which both effects were
observed for controls. Moreover, the identical kinetics of NPN
FIG. 3. Effects of polymyxin B on the OMs of B. abortus and E. coli. Electron
microscope pictures of E. coli O111 after exposure to polymyxin B at 500 U/ml
for 20 min at 378C (A) and B. abortus 2308 after exposure to polymyxin B at 500
U/ml for 20 min at 378C (B). (C) Cell lysis induced by exposure to polymyxin B
(100 U/ml) and lysozyme (50 mg/ml).
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partition into the OMs of Brucella spp. in the absence and
presence of EDTA and cationic peptides contrasted with the
effects observed for the two complementary controls used (E.
coli and H. influenzae). Since it is known that little changes in
the OMs of gram-negative bacteria caused by cationic peptides
instantaneously alter the partition of NPN into the OM (29, 30,
36, 45), the results of fluorimetric experiments extend the re-
sults obtained in binding experiments with whole cells. The fact
that H. influenzae and Brucella OMs presented similar levels of
permeability to hydrophobic probes but different sensitivities
to EDTA and cationic peptides also means that, in general,
there is no tight connection between the ionic groups which
allow the electrostatic binding of cationic peptides and the
impermeability of OMs to hydrophobic agents.
In other gram-negative bacteria, LPS is the major target
of several cationic peptides (Table 2); therefore, it is not
surprising that LPS plays a role in the resistance of Brucella
spp. to polycationic compounds at both the O-chain and
core lipid A levels. A role for the O chain can be postulated
since S B. abortus was more resistant than R B. abortus was and
since coating the latter with homologous S-LPS increased re-
sistance. Obviously, this could account in part for the well-
known, yet unexplained loss of virulence in R Brucella mutants
(5). An overall anionic charge on the surface of R B. abortus
has previously been shown (47); as in other gram-negative
bacteria (4, 27, 41), the O polysaccharide could simply mask
inner anionic sites. In addition, the composition of Brucella O
polysaccharide (a homopolymer of N-formyl-perosamine [26])
could enhance the effect of polysaccharide length, since B.
abortus O-chain-bearing Y. enterocolitica O:9 (26) was less af-
fected by subinhibitory polymyxin B concentrations than E. coli
O111 was. A major role for the core lipid A of Brucella LPS is
demonstrated by the resistance of R Brucella mutants and B.
ovis and by binding experiments with purified LPSs. Since
phosphate and KDO are the LPS sites with affinities for poly-
myxin B and cations (41, 45) and the core lipid A of Brucella
LPS contains reduced amounts of KDO (23), this could ac-
count in part for comparatively reduced affinity. Moreover, the
fact that the ratio of bound polymyxin B to nanomoles of KDO
for E. coli and S. montevideo was higher than that for B. abortus
suggests the unavailability on Brucella LPS of anionic binding
sites other than KDO, perhaps in relation to the absence of
phosphate in lipid A (23). The shielding of LPS anionic groups
by cationic ornithine lipids has also been suggested as a mech-
anism of resistance (20), and although we found that S-LPS
purified of lipids had the same reduced affinity for cationic
peptides, such shielding could be an additional resistance fac-
tor in an intact OM.
The results of this research demonstrate that the OMs of
Brucella spp. have properties that are helpful in withstanding
the actions of relevant components of the oxygen-independent
systems of phagocytes. Moreover, they suggest subtle differ-
FIG. 4. Effects of EDTA, polymyxin B, and cationic peptides on the partition
of NPN into the OMs of live cells of E. coli O111 K58H2 (upper panels), H.
influenzae 9193 (middle panels), and B. abortus 2308 (lower panels). Arrows
indicate the times of addition of the agent(s) listed and NPN, and fluorescence
(in RFU) corresponding to polymyxin B and peptides has been plotted. The
discontinuous line in the lower right panel corresponds to a control in which
NPN was added to B. abortus 2308 cells previously damaged by heating. Discon-
tinuous lines in all other panels are control experiments with viable cells and
NPN only.
FIG. 5. Polymyxin B binding by enterobacterial-type S-LPS (E. coli) (h) and
Brucella-type S-LPS (B. abortus) (E) according to LPS dry weight (A) and
nanomoles of KDO (B).
TABLE 4. Activities of cationic peptides against R B. abortus 45/20
coated with S-LPSs from S B. abortus and S. montevideoa
Agent
Coating
None B. abortusS19 S-LPS
S. montevideo
S-LPS
Bactenecin 7 8.6 6 2.2 7.4 6 0.9 98.7 6 1.1
CAP18 9.9 6 1.7 7.2 6 0.5b 97.8 6 0.5
Lactoferricin B 23.1 6 1.0 17.2 6 0.8c 97.4 6 2.3
Melittin 31.6 6 2.5 16.4 6 1.1c 99.1 6 0.4
Polymyxin B 23.9 6 1.0 8.9 6 0.7c 99.1 6 0.9
Poly-L-ornithine 14.7 6 3.4 11.1 6 2.0d 98.1 6 1.4
a See Table 3, footnote a.
b Significantly different from the results for uncoated controls (P , 0.01).
c Significantly different from the results for uncoated controls (P , 0.001).
d Significantly different from the results for uncoated controls (P , 0.02).
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ences among Brucella species. In a previous study, we found
differences in the kinetics of NPN partition into the OM be-
tween B. ovis on one hand and B. melitensis and B. abortus on
the other (21) that could be related to their respective LPS
structures, and in this work, we observed that B. ovis was
extremely sensitive to bovine bactenecin 7. Unfortunately,
little is known of the structure of either bovine bactenecin 7
or B. ovis LPS. However, since B. ovis infections are restricted
to sheep (5), it is tempting to speculate that differences in
OM and host defense peptides account in part for known
differences in virulence and host range among Brucella species
(5).
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